Cardiac Monitoring & Cardiac Rhythm Management Market by Product and End User - Global Industry Analysis and Forecast to 2025

Published On : June 2017 Pages : 120 Category: Medical Devices Report Code : HC0696 Format :

Industry Trend Analysis

The cardiac monitoring & cardiac rhythm management market is expected to be worth $XX billion by 2025. The market is largely driven by factors such as rising incidence of cardiovascular disorders along with technological advancements in cardiac monitoring & cardiac rhythm management devices. According to a report published by American Heart Association in 2017, around 92.1 million American adults are living with some or other type of cardiovascular disease. The estimated number of new heart attacks in U.S. is 580,000 with 210,000 incidences of recurrent attacks.  Moreover, increasing geriatric population around the world also contributes substantially to the market growth as older adults are more susceptible to cardiovascular disorders such as stroke, heart failure, congenital heart disease, angina, arrhythmia and myocardial infarction. However, high cost of devices, inadequate insurance coverage and more preference for drugs is expected to slow down growth of the cardiac monitoring and rhythm management market.

Product Outlook and Trend Analysis

The electrocardiogram (ECG) devices segment held the major share of the cardiac monitoring devices market in 2016 owing to their critical benefits in detecting cardiac infarction, coronary vessel diseases, lack or abundance of certain minerals and their influence on impulse conduction and atrial fibrillation or atrial flutter. Event monitors segment is expected to grow with the fastest growth rate during the forecast period owing to their small size and light weight which makes them convenient to be carried to the patient’s site. The defibrillators segment is expected to hold the largest share of the cardiac rhythm management market during the forecast period owing to large scale adoption of defibrillators around the world along with rising incidence of sudden heart attacks (SCA).

End User Outlook and Trend Analysis

Hospitals and clinics segment accounted for the majority share of the overall market in 2016 due to the large scale adoption of cardiac monitoring & cardiac rhythm management devices in hospital settings to treat patients suffering from acute and chronic cardiovascular diseases. Ambulatory surgical centers segment is expected to witness fastest growth during the forecast period due to the advent of advanced devices which enable cost effective cardiac monitoring and management as compared to hospital based treatment.

Regional Outlook and Trend Analysis

North America held a major share of the cardiac monitoring & cardiac rhythm management market in 2016 owing to rising incidence of heart failure and arrhythmia accompanied by increasing geriatric population. Also, availability of favorable reimbursement policies related to cardiac monitoring & cardiac rhythm management devices in the region is expected to largely contribute to the robust growth of North American market. Asia-Pacific cardiac monitoring & cardiac rhythm management market is expected to exhibit fastest growth over the forecast period due to the presence of highly unmet medical needs in the region along with increasing disposable income of the population in the region. 

Competitive Insights

The major players operating in the global cardiac monitoring & cardiac rhythm management market emphasize on product development in order to introduce advanced products in accordance with the changing needs and demands of the market. For instance, in May 2017, Abbott Laboratories announced the CE Mark and first use of its new Confirm Rx Insertable Cardiac Monitor (ICM). It is the world’s first ICM that is compatible with a smartphone which will help physicians in detecting cardiac arrhythmias including atrial fibrillation.

Some of the key players operating in the cardiac monitoring & cardiac rhythm management market are, Abiomed, Berlin Heart GmbH, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Koninklijke Philips N.V.,  Cardiac Science Corporation, General Electric Company, LivaNova PLC, Medtronic plc, Nihon Kohden Corporation, ReliantHeart Inc., Schiller AG and St. Jude Medical, LLC.

Market Opportunities

The key opportunity for the players operating in cardiac monitoring & cardiac rhythm management market lies in the development of technologically advanced products which deliver enhanced value to the patients suffering from cardiovascular diseases. Also, miniaturization of products has been a growing trend in the market which largely improves the convenience of use of cardiac monitoring and rhythm management devices. With increasing disposable income in the emerging markets with prevalence of unmet medical needs, market players can largely benefit by expanding distribution to such markets and secure competitive advantage.

Cardiac Monitoring & Cardiac Rhythm Management Market Segmentation:

By Product:

  • Cardiac Monitoring Devices
  • Electrocardiogram (ECG) Devices
    • ECG Devices, By Type
      • Stress ECG
      • Resting ECG
      • Holter Monitors
    • ECG Devices, By Lead Type
      • Single Lead
      • 12 Lead
      • 3-6 Lead
  • Cardiac Output Monitoring
    • Noninvasive COM
    • Minimally Invasive COM
  • Implantable Loop Recorder
  • Event Monitors
    • Event Monitors, By Type
      • Pre-symptom
      • Post-symptom
    • Event Monitors, By Technology
      • Autodetect Monitors
      • Manual Event Monitors
  • Cardiac Rhythm Management Devices
  • Pacemakers
    • Implantable Pacemakers
    • External Pacemakers
  • Defibrillators
    • Implantable Cardioverter Defibrillators (ICDs)
      • Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
      • Dual-chamber ICDs
      • Single-chamber ICDs
      • Subcutaneous Implantable Cardioverter Defibrillator (S-ICD)
    • External Defibrillator
      • Manual External Defibrillator
      • Automated External Defibrillator (AEDs)
      • Semi-automated External Defibrillator
      • Fully Automated External Defibrillator
      • Wearable Cardioverter Defibrillator (WCDs)
  • Cardiac Resynchronization Therapy (CRT) Devices
    • CRT-P (CRT with Pacemaker Function)
    • CRT-D (CRT with Pacemaker and ICD Function)
  • Ventricular Assist Devices (VADs)
    • Right Ventricular Assist Device (RVAD)
    • Left Ventricular Assist Device (LVAD)
    • Biventricular Assist Device (BIVAD)

By End User:

  • Hospitals & Clinics
  • Home Settings
  • Ambulatory Surgical Centers (ASCs)

By Region:

  • North America
  • U.S
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia Pacific
  • Rest of the World
  • Brazil
  • South Africa
  • Saudi Arabia
  • United Arab Emirates
  • Others

Some of the key questions answered by the report are:

  • What was the market size in 2016 and forecast from 2017 to 2025?
  • What will be the industry market growth from 2017 to 2025?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

  • Cardiac Monitoring & Cardiac Rhythm Management Market, By Product, Estimates and Forecast, 2016-2025 ($Million)
  • Cardiac Monitoring Devices
  • Electrocardiogram (ECG) Devices
    • ECG Devices by Type
      • Stress ECG
      • Resting ECG
      • Holter Monitors
    • ECG Devices by Lead Type
      • Single Lead
      • 12 Lead
      • 3-6 Lead
  • Cardiac Output Monitoring
    • Noninvasive COM
    • Minimally Invasive COM
  • Implantable Loop Recorder
  • Event Monitors
    • By Type
      • Pre-symptom
      • Post-symptom
    • By Technology
      • Autodetect Monitors
      • Manual Event Monitors
  • Cardiac Rhythm Management Devices
  • Pacemakers
    • Implantable Pacemakers
    • External Pacemakers
  • Defibrillators
    • Implantable Cardioverter Defibrillators (ICDs)
      • Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
      • Dual-chamber ICDs
      • Single-chamber ICDs
      • Subcutaneous Implantable Cardioverter Defibrillator (S-ICD)
  • External Defibrillator
    • Manual External Defibrillator
    • Automated External Defibrillator (AEDs)
      • Semi-automated External Defibrillator
      • Fully Automated External Defibrillator
      • Wearable Cardioverter Defibrillator (WCDs)
    • Cardiac Resynchronization Therapy (CRT) Devices
      • CRT-P (CRT with Pacemaker Function)
      • CRT-D (CRT with Pacemaker and ICD Function)
    • Ventricular Assist Devices (VADs)
      • Right Ventricular Assist Device (RVAD)
      • Left Ventricular Assist Device (LVAD)
        • Biventricular Assist Device (BIVAD)
  • Cardiac Monitoring & Cardiac Rhythm Management Market, By End User, Estimates and Forecast, 2016-2025 ($Million)
    • Hospitals & Clinics
    • Home Settings
    • Ambulatory Surgical Centers (ASCs)
  • Cardiac Monitoring & Cardiac Rhythm Management Market, By Region, Estimates and Forecast, 2016-2025 ($Million)
    • North America
  • North America Cardiac Monitoring & Cardiac Rhythm Management Market, By Country
  • North America Cardiac Monitoring & Cardiac Rhythm Management Market, By Product
  • North America Cardiac Monitoring & Cardiac Rhythm Management Market, By End User
    • U.S. Cardiac Monitoring & Cardiac Rhythm Management Market, By Product
    • U.S. Cardiac Monitoring &Cardiac Rhythm Management Market, By End User
    • Canada Cardiac Monitoring & Cardiac Rhythm Management Market, By Product
    • Canada Cardiac Monitoring & Cardiac Rhythm Management Market, By End User
    • Mexico Cardiac Monitoring & Cardiac Rhythm Management Market, By Product
    • Mexico Cardiac Monitoring & Cardiac Rhythm Management Market, By End User
    • Europe
  • Europe Cardiac Monitoring & Cardiac Rhythm Management Market, By Country
  • Europe Cardiac Monitoring & Cardiac Rhythm Management Market, By Product
  • Europe Cardiac Monitoring & Cardiac Rhythm Management Market, By End User
    • Germany Cardiac Monitoring & Cardiac Rhythm Management Market, By Product
    • Germany Cardiac Monitoring & Cardiac Rhythm Management Market, By End User
    • France Cardiac Monitoring & Cardiac Rhythm Management Market, By Product
    • France Cardiac Monitoring & Cardiac Rhythm Management Market, By End User
    • UK Cardiac Monitoring & Cardiac Rhythm Management Market, By Product
    • UK Cardiac Monitoring & Cardiac Rhythm Management Market, By End User
    • Italy Cardiac Monitoring & Cardiac Rhythm Management Market, By Product
    • Italy Cardiac Monitoring & Cardiac Rhythm Management Market, By End User
    • Spain Cardiac Monitoring & Cardiac Rhythm Management Market, By Product
    • Spain Cardiac Monitoring & Cardiac Rhythm Management Market, By End User
    • Rest of Europe Cardiac Monitoring & Cardiac Rhythm Management Market, By Product
    • Rest of Europe Cardiac Monitoring & Cardiac Rhythm Management Market, By End User
    • Asia-Pacific
      • Asia-Pacific Cardiac Monitoring & Cardiac Rhythm Management Market, By Country
      • Asia-Pacific Cardiac Monitoring & Cardiac Rhythm Management Market, By Product
      • Asia-Pacific Cardiac Monitoring & Cardiac Rhythm Management Market, By End User
        • Japan Cardiac Monitoring & Cardiac Rhythm Management Market, By Product
        • Japan Cardiac Monitoring & Cardiac Rhythm Management Market, By End User
        • Australia Cardiac Monitoring & Cardiac Rhythm Management Market, By Product
        • Australia Cardiac Monitoring & Cardiac Rhythm Management Market, By End User
        • India Cardiac Monitoring & Cardiac Rhythm Management Market, By Product
        • India Cardiac Monitoring & Cardiac Rhythm Management Market, By End User
        • South Korea Cardiac Monitoring & Cardiac Rhythm Management Market, By Product
        • South Korea Cardiac Monitoring & Cardiac Rhythm Management Market, By End User
        • Rest of Asia-Pacific Cardiac Monitoring & Cardiac Rhythm Management Market, By Product
        • Rest of Asia-Pacific Cardiac Monitoring & Cardiac Rhythm Management Market, By End User
    • Rest of the World
      • Rest of the World Cardiac Monitoring & Cardiac Rhythm Management Market, By Country
      • Rest of the World Cardiac Monitoring & Cardiac Rhythm Management Market, By Product
      • Rest of the World Cardiac Monitoring & Cardiac Rhythm Management Market, By End User
        • Brazil Cardiac Monitoring & Cardiac Rhythm Management Market, By Product
        • Brazil Cardiac Monitoring & Cardiac Rhythm Management Market, By End User
        • South Africa Cardiac Monitoring & Cardiac Rhythm Management Market, By Product
        • South Africa Cardiac Monitoring & Cardiac Rhythm Management Market, By End User
        • Saudi Arabia Cardiac Monitoring & Cardiac Rhythm Management Market, By Product
        • Saudi Arabia Cardiac Monitoring & Cardiac Rhythm Management Market, By End User
        • Turkey Cardiac Monitoring & Cardiac Rhythm Management Market, By Product
        • Turkey Cardiac Monitoring & Cardiac Rhythm Management Market, By End User
        • United Arab Emirates Cardiac Monitoring & Cardiac Rhythm Management Market, By Product
        • United Arab Emirates Cardiac Monitoring & Cardiac Rhythm Management Market, By End User
        • Others Cardiac Monitoring & Cardiac Rhythm Management Market, By Product
        • Others Cardiac Monitoring & Cardiac Rhythm Management Market, By End User

Table of Contents

1.Introduction

1.1.Report Description

1.2.Research Methodology

2.Executive Summary

2.1.Key Highlights

3.Market Overview

3.1.Introduction

3.1.1. Market Definition

3.1.2. Market Segmentation

3.2.Market Share Analysis

3.3.Market Dynamics

3.3.1. Drivers

3.3.1.1.Increasing Incidence of Cardiovascular Diseases Globally

3.3.1.2.Increasing Geriatric Population Worldwide

3.3.1.3.Technological Advancements in Cardiac Monitoring & Cardiac Rhythm Management Devices

3.3.1.4.Increasing Patient Awareness towards Cardiovascular Diseases

3.3.2. Restraints

3.3.2.1.High Cost of Devices

3.3.2.2.Inadequate Insurance Coverage

3.3.2.3.More Preference towards Drugs by Patients

3.3.3. Opportunities

3.3.3.1.Emerging Markets to Offer Lucrative Growth Opportunities

3.4.Industry Trends

4.Cardiac Monitoring & Cardiac Rhythm Management Market, By Product

4.1.Introduction

4.2.Cardiac Monitoring & Cardiac Rhythm Management Market Assessment and Forecast, By Product, 2016-2025

4.3.Cardiac Monitoring Devices

4.4.Market Assessment and Forecast, By Type, 2016-2025 ($Million)

4.5.Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.5.1. Electrocardiogram (ECG) Devices

4.5.2. Market Assessment and Forecast, By Type, 2016-2025 ($Million)

4.5.3. Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.5.4. ECG Devices, By Type

4.5.5. Market Assessment and Forecast, By Type, 2016-2025 ($Million)

4.5.6. Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.5.6.1.Stress ECG

4.5.6.2.Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.5.6.3.Resting ECG

4.5.6.4.Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.5.6.5.Holter Monitors

4.5.6.6.Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.5.7. ECG Devices, By Lead Type

4.5.8. Market Assessment and Forecast, By Type, 2016-2025 ($Million)

4.5.9. Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.5.9.1.Single Lead

4.5.9.2.Market Assessment and Forecast, By Region, 2016-2025 ($Million)

 

4.5.9.3.12 Lead

4.5.9.4.Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.5.9.5.3-6 Lead

4.5.9.6.Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.5.10.Cardiac Output Monitoring

4.5.11.Market Assessment and Forecast, By Type, 2016-2025 ($Million)

4.5.12.Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.5.12.1.Noninvasive COM

4.5.12.2.Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.5.12.3.Minimally Invasive COM

4.5.12.4.Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.5.12.5.Implantable Loop Recorder

4.5.12.6.Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.5.13.Event Monitors

4.5.14.Market Assessment and Forecast, By Type, 2016-2025 ($Million)

4.5.15.Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.5.16.Event Monitors, By Type

4.5.17.Market Assessment and Forecast, By Type, 2016-2025 ($Million)

4.5.18.Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.5.18.1.Pre-symptom

4.5.18.2.Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.5.18.3.Post-symptom

4.5.18.4.Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.5.19.Event Monitors, By Technology

4.5.20.Market Assessment and Forecast, By Type, 2016-2025 ($Million)

4.5.21.Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.5.21.1.Autodetect Monitors

4.5.21.2.Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.5.21.3.Manual Event Monitors

4.5.21.4.Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.6.Cardiac Rhythm Management Devices

4.6.1. Pacemakers

4.6.2. Market Assessment and Forecast, By Type, 2016-2025 ($Million)

4.6.3. Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.6.3.1.Implantable Pacemakers

4.6.3.2.Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.6.3.3.External Pacemakers

4.6.3.4.Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.6.4. Defibrillators

4.6.5. Market Assessment and Forecast, By Type, 2016-2025 ($Million)

4.6.6. Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.6.6.1.Implantable Cardioverter Defibrillators (ICDs)

4.6.6.2.Market Assessment and Forecast, By Type, 2016-2025 ($Million)

4.6.6.3.Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.6.6.3.1.Transvenous Implantable Cardioverter Defibrillator (T-ICDs)

4.6.6.3.2.Market Assessment and Forecast, By Type, 2016-2025 ($Million)

4.6.6.3.3.Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.6.6.3.3.1.Dual-chamber ICDs

4.6.6.3.3.2.Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.6.6.3.3.3.Single-chamber ICDs

4.6.6.3.3.4.Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.6.6.3.4.Subcutaneous Implantable Cardioverter Defibrillator (S-ICD)

4.6.6.3.5.Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.6.6.4.External Defibrillator

4.6.6.5.Market Assessment and Forecast, By Type, 2016-2025 ($Million)

4.6.6.6.Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.6.6.6.1.Manual External Defibrillator

4.6.6.6.2.Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.6.6.6.3.Automated External Defibrillator (AEDs)

4.6.6.6.4.Market Assessment and Forecast, By Type, 2016-2025 ($Million)

4.6.6.6.5.Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.6.6.6.5.1.Semi-automated External Defibrillator

4.6.6.6.5.2.Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.6.6.6.5.3.Fully Automated External Defibrillator

4.6.6.6.5.4.Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.6.6.6.6.Wearable Cardioverter Defibrillator (WCDs)

4.6.6.6.7.Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.6.7. Cardiac Resynchronization Therapy (CRT) Devices

4.6.8. Market Assessment and Forecast, By Type, 2016-2025 ($Million)

4.6.9. Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.6.9.1.CRT-P (CRT with Pacemaker Function)

4.6.9.2.Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.6.9.3.CRT-D (CRT with Pacemaker and ICD Function)

4.6.9.4.Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.6.10.Ventricular Assist Devices (VADs)

4.6.11.Market Assessment and Forecast, By Type, 2016-2025 ($Million)

4.6.12.Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.6.12.1.Right Ventricular Assist Device (RVAD)

4.6.12.2.Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.6.12.3.Left Ventricular Assist Device (LVAD)

4.6.12.4.Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.6.12.5.Biventricular Assist Device (BIVAD)

4.6.12.6.Market Assessment and Forecast, By Region, 2016-2025 ($Million)

5.Cardiac Monitoring & Cardiac Rhythm Management Market, By End User

5.1.Introduction

5.2.The Cardiac Monitoring & Cardiac Rhythm Management Market Assessment and Forecast, By End User, 2016-2025

5.2.1. Hospitals & Clinics

5.2.1.1.Market Assessment and Forecast, By Region, 2016-2025 ($Million)

5.2.2. Home Settings

5.2.2.1.Market Assessment and Forecast, By Region, 2016-2025 ($Million)

5.2.3. Ambulatory Surgical Centers (ASCs)

5.2.4. Market Assessment and Forecast, By Region, 2016-2025 ($Million)

6.Cardiac Monitoring & Cardiac Rhythm Management Market, By Region

6.1.Introduction

6.2.Cardiac Monitoring & Cardiac Rhythm Management Market Assessment and Forecast, By Product, 2016-2025 ($Million)

6.3.Cardiac Monitoring & Cardiac Rhythm Management Market Assessment and Forecast, By End User, 2016-2025 ($Million)

6.4.North America

6.4.1. Market Assessment and Forecast, By Country, 2016-2025 ($Million)

6.4.2. Market Assessment and Forecast, By Product, 2016-2025 ($Million)

6.4.3. Market Assessment and Forecast, By End User, 2016-2025 ($Million)

6.4.3.1.U.S.

6.4.3.1.1.Market Assessment and Forecast, By Product, 2016-2025 ($Million)

6.4.3.1.2.Market Assessment and Forecast, By End User, 2016-2025 ($Million)

6.4.3.2.Canada

6.4.3.2.1.Market Assessment and Forecast, By Product, 2016-2025 ($Million)

6.4.3.2.2.Market Assessment and Forecast, By End User, 2016-2025 ($Million)

6.4.3.3.Mexico

6.4.3.3.1.Market Assessment and Forecast, By Product, 2016-2025 ($Million)

6.4.3.3.2.Market Assessment and Forecast, By End User, 2016-2025 ($Million)

6.5.Europe

6.5.1. Market Assessment and Forecast, By Country, 2016-2025 ($Million)

6.5.2. Market Assessment and Forecast, By Product, 2016-2025 ($Million)

6.5.3. Market Assessment and Forecast, By End User, 2016-2025 ($Million)

6.5.3.1.Germany

6.5.3.1.1.Market Assessment and Forecast, By Product, 2016-2025 ($Million)

6.5.3.1.2.Market Assessment and Forecast, By End User, 2016-2025 ($Million)

6.5.3.2.France

6.5.3.2.1.Market Assessment and Forecast, By Product, 2016-2025 ($Million)

6.5.3.2.2.Market Assessment and Forecast, By End User, 2016-2025 ($Million)

6.5.3.3.UK

6.5.3.3.1.Market Assessment and Forecast, By Product, 2016-2025 ($Million)

6.5.3.3.2.Market Assessment and Forecast, By End User, 2016-2025 ($Million)

6.5.3.4.Italy

6.5.3.4.1.Market Assessment and Forecast, By Product, 2016-2025 ($Million)

6.5.3.4.2.Market Assessment and Forecast, By End User, 2016-2025 ($Million)

6.5.3.5.Spain

6.5.3.5.1.Market Assessment and Forecast, By Product, 2016-2025 ($Million)

6.5.3.5.2.Market Assessment and Forecast, By End User, 2016-2025 ($Million)

6.5.3.6.Russia

6.5.3.6.1.Market Assessment and Forecast, By Product, 2016-2025 ($Million)

6.5.3.6.2.Market Assessment and Forecast, By End User, 2016-2025 ($Million)

6.5.3.7.Rest of Europe

6.5.3.7.1.Market Assessment and Forecast, By Product, 2016-2025 ($Million)

6.5.3.7.2.Market Assessment and Forecast, By End User, 2016-2025 ($Million)

6.6.Asia-Pacific

6.6.1. Market Assessment and Forecast, By Country, 2016-2025 ($Million)

6.6.2. Market Assessment and Forecast, By Product, 2016-2025 ($Million)

6.6.3. Market Assessment and Forecast, By End User, 2016-2025 ($Million)

6.6.3.1.Japan

6.6.3.1.1.Market Assessment and Forecast, By Product, 2016-2025 ($Million)

6.6.3.1.2.Market Assessment and Forecast, By End User, 2016-2025 ($Million)

6.6.3.2.China

6.6.3.2.1.Market Assessment and Forecast, By Product, 2016-2025 ($Million)

6.6.3.2.2.Market Assessment and Forecast, By End User, 2016-2025 ($Million)

6.6.3.3.Australia

6.6.3.3.1.Market Assessment and Forecast, By Product, 2016-2025 ($Million)

6.6.3.3.2.Market Assessment and Forecast, By End User, 2016-2025 ($Million)

6.6.3.4.India

6.6.3.4.1.Market Assessment and Forecast, By Product, 2016-2025 ($Million)

6.6.3.4.2.Market Assessment and Forecast, By End User, 2016-2025 ($Million)

6.6.3.5.South Korea

6.6.3.5.1.Market Assessment and Forecast, By Product, 2016-2025 ($Million)

6.6.3.5.2.Market Assessment and Forecast, By End User, 2016-2025 ($Million)

6.6.3.6.Taiwan

6.6.3.6.1.Market Assessment and Forecast, By Product, 2016-2025 ($Million)

6.6.3.6.2.Market Assessment and Forecast, By End User, 2016-2025 ($Million)

6.6.3.7.Rest of Asia-Pacific

6.6.3.7.1.Market Assessment and Forecast, By Product, 2016-2025 ($Million)

6.6.3.7.2.Market Assessment and Forecast, By End User, 2016-2025 ($Million)

6.7.Rest of the World

6.7.1. Market Assessment and Forecast, By Country, 2016-2025 ($Million)

6.7.2. Market Assessment and Forecast, By Product, 2016-2025 ($Million)

6.7.3. Market Assessment and Forecast, By End User, 2016-2025 ($Million)

6.7.3.1.Brazil

6.7.3.1.1.Market Assessment and Forecast, By Product, 2016-2025 ($Million)

6.7.3.1.2.Market Assessment and Forecast, By End User, 2016-2025 ($Million)

6.7.3.2.Turkey

6.7.3.2.1.Market Assessment and Forecast, By Product, 2016-2025 ($Million)

6.7.3.2.2.Market Assessment and Forecast, By End User, 2016-2025 ($Million)

6.7.3.3.Saudi Arabia

6.7.3.3.1.Market Assessment and Forecast, By Product, 2016-2025 ($Million)

6.7.3.3.2.Market Assessment and Forecast, By End User, 2016-2025 ($Million)

6.7.3.4.South Africa

6.7.3.4.1.Market Assessment and Forecast, By Product, 2016-2025 ($Million)

6.7.3.4.2.Market Assessment and Forecast, By End User, 2016-2025 ($Million)

6.7.3.5.United Arab Emirates

6.7.3.5.1.Market Assessment and Forecast, By Product, 2016-2025 ($Million)

6.7.3.5.2.Market Assessment and Forecast, By End User, 2016-2025 ($Million)

6.7.3.6.Others

6.7.3.6.1.Market Assessment and Forecast, By Product, 2016-2025 ($Million)

6.7.3.6.2.Market Assessment and Forecast, By End User, 2016-2025 ($Million)

7.Company Profiles

7.1.Abiomed

7.1.1. Business Overview

7.1.2. Product Portfolio

7.1.3. Key Financials

7.1.4. Strategic Developments

7.2.Berlin Heart GmbH

7.2.1. Business Overview

7.2.2. Product Portfolio

7.2.3. Strategic Developments

7.3.BIOTRONIK SE & Co. KG

7.3.1. Business Overview

7.3.2. Product Portfolio

7.3.3. Strategic Developments

7.4.Boston Scientific Corporation

7.4.1. Business Overview

7.4.2. Product Portfolio

7.4.3. Key Financials

7.4.4. Strategic Developments

7.5.Koninklijke Philips N.V.

7.5.1. Business Overview

7.5.2. Product Portfolio

7.5.3. Key Financials

7.5.4. Strategic Developments

7.6.Cardiac Science Corporation

7.6.1. Business Overview

7.6.2. Product Portfolio

7.6.3. Strategic Developments

7.7.General Electric Company

7.7.1. Business Overview

7.7.2. Product Portfolio

7.7.3. Key Financials

7.7.4. Strategic Developments

7.8.LivaNova PLC

7.8.1. Business Overview

7.8.2. Product Portfolio

7.8.3. Key Financials

7.8.4. Strategic Developments

7.9.Medtronic plc

7.9.1. Business Overview

7.9.2. Product Portfolio

7.9.3. Key Financials

7.9.4. Strategic Developments

7.10.Nihon Kohden Corporation

7.10.1.Business Overview

7.10.2.Product Portfolio

7.10.3.Key Financials

7.10.4.Strategic Developments

7.11.Schiller AG

7.11.1.Business Overview

7.11.2.Product Portfolio

7.11.3.Strategic Developments

7.12.ReliantHeart Inc.

7.12.1. Business Overview

7.12.2.Product Portfolio

7.12.3.Strategic Developments

7.13.Abbott Laboratories

7.13.1.Business Overview

7.13.2.Product Portfolio

7.13.3.Key Financials

7.13.4.Strategic Developments


List of Tables

Table 1.Cardiac Monitoring & Cardiac Rhythm Management Market, By Product ($Million), 2016-2025
Table 2.Cardiac Monitoring Devices Market, By Type ($Million), 2016-2025
Table 3.Cardiac Monitoring Devices Market, By Region ($Million), 2016-2025
Table 4.Electrocardiogram (ECG) Devices Market, By Type ($Million), 2016-2025
Table 5.Electrocardiogram (ECG) Devices Market, By Region ($Million), 2016-2025
Table 6.ECG Devices by Type Market, By Type ($Million), 2016-2025
Table 7.ECG Devices by Type Market, By Region ($Million), 2016-2025
Table 8.Stress ECG Market, By Region ($Million), 2016-2025
Table 9.Resting ECG Market, By Region ($Million), 2016-2025
Table 10.Holter Monitors Market, By Region ($Million), 2016-2025
Table 11.ECG Devices by Lead Type Market, By Type ($Million), 2016-2025
Table 12.ECG Devices by Lead Type Market, By Region ($Million), 2016-2025
Table 13.Single Lead Market, By Region ($Million), 2016-2025
Table 14.12 Lead Market, By Region ($Million), 2016-2025
Table 15.3-6 Lead Market, By Region ($Million), 2016-2025
Table 16.Cardiac Output Monitoring Market, By Type ($Million), 2016-2025
Table 17.Cardiac Output Monitoring Market, By Region ($Million), 2016-2025
Table 18.Noninvasive COM Market, By Region ($Million), 2016-2025
Table 19.Minimally Invasive COM Market, By Region ($Million), 2016-2025
Table 20.Implantable Loop Recorder Market, By Region ($Million), 2016-2025
Table 21.Event Monitors Market, By Type ($Million), 2016-2025
Table 22.Event Monitors Market, By Region ($Million), 2016-2025
Table 23.Pre-symptom Event Monitors Market, By Region ($Million), 2016-2025
Table 24.Autodetect Monitors Market, By Region ($Million), 2016-2025
Table 25.Manual Event Monitors Market, By Region ($Million), 2016-2025
Table 26.Cardiac Rhythm Management Devices Market, By Type ($Million), 2016-2025
Table 27.Cardiac Rhythm Management Devices Market, By Region ($Million), 2016-2025
Table 28.Pacemakers Market, By Type ($Million), 2016-2025
Table 29.Pacemakers Market, By Region ($Million), 2016-2025
Table 30 .Implantable Pacemakers Market, By Region ($Million), 2016-2025
Table 31.External Pacemakers Market, By Region ($Million), 2016-2025
Table 32.Defibrillators Market, By Type ($Million), 2016-2025
Table 33.Defibrillators Market, By Region ($Million), 2016-2025
Table 34.Implantable Cardioverter Defibrillators (ICDs) Market, By Type ($Million), 2016-2025
Table 35.Implantable Cardioverter Defibrillators (ICDs) Market, By Region ($Million), 2016-2025
Table 36.Transvenous Implantable Cardioverter Defibrillator (T-ICDs) Market, By Type ($Million), 2016-2025
Table 37.Transvenous Implantable Cardioverter Defibrillator (T-ICDs) Market, By Region ($Million), 2016-2025
Table 38.Dual-chamber ICDs Market, By Region ($Million), 2016-2025
Table 39.Single-chamber ICDs Market, By Region ($Million), 2016-2025
Table 40.Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) Market, By Region ($Million), 2016-2025
Table 41.External Defibrillators Market, By Type ($Million), 2016-2025
Table 42.External Defibrillators Market, By Region ($Million), 2016-2025
Table 43.Manual External Defibrillators Market, By Region ($Million), 2016-2025
Table 44.Automated External Defibrillator (AEDs) Market, By Type ($Million), 2016-2025
Table 45.Automated External Defibrillator (AEDs) Market, By Region ($Million), 2016-2025
Table 46.Semi-automated External Defibrillator (AEDs) Market, By Region ($Million), 2016-2025
Table 47.Fully Automated External Defibrillator (AEDs) Market, By Region ($Million), 2016-2025
Table 48.Wearable Cardioverter Defibrillator (WCDs) Market, By Region ($Million), 2016-2025
Table 49.Cardiac Resynchronization Therapy (CRT) Devices Market, By Type ($Million), 2016-2025
Table 50.Cardiac Resynchronization Therapy (CRT) Devices Market, By Region ($Million), 2016-2025
Table 51.CRT-P Market, By Region ($Million), 2016-2025
Table 52.CRT-D Market, By Region ($Million), 2016-2025
Table 53.Ventricular Assist Devices (VADs) Market, By Type ($Million), 2016-2025
Table 54.Ventricular Assist Devices (VADs) Market, By Region ($Million), 2016-2025
Table 55.Right Ventricular Assist Device (RVAD) Market, By Region ($Million), 2016-2025
Table 56.Semi Left Ventricular Assist Device (LVAD) Market, By Region ($Million), 2016-2025
Table 57.Biventricular Assist Device (BIVAD) Market, By Region ($Million), 2016-2025
Table 58.Cardiac Monitoring & Cardiac Rhythm Management Market, By End User ($Million), 2016-2025
Table 59.Hospitals & Clinics Market, By Region ($Million), 2016-2025
Table 60.Home Settings Market, By Region ($Million), 2016-2025
Table 61.Ambulatory Surgical Centers (ASCs) Market, By Region ($Million), 2016-2025
Table 62.Cardiac Monitoring & Cardiac Rhythm Management Market, By Region ($Million), 2016-2025
Table63.North America Cardiac Monitoring & Cardiac Rhythm Management Market, By Country, 2016-2025 ($Million)
Table64.North America Cardiac Monitoring & Cardiac Rhythm Management Market, By Product, 2016-2025 ($Million)
Table 65.North America Cardiac Monitoring & Cardiac Rhythm Management Market, By End User, 2016-2025 ($Million)
Table 66.U.S. Cardiac Monitoring & Cardiac Rhythm Management Market, by Product, 2016-2025 ($Million)
Table 67.U.S. Cardiac Monitoring & Cardiac Rhythm Management Market, by End User, 2016-2025 ($Million)
Table 68.Canada Cardiac Monitoring & Cardiac Rhythm Management Market, By Product, 2016-2025 ($Million)
Table 69.Canada Cardiac Monitoring & Cardiac Rhythm Management Market, By End User, 2016-2025 ($Million)
Table 70.Mexico Cardiac Monitoring & Cardiac Rhythm Management Market, By Product, 2016-2025 ($Million)
Table 71.Mexico Cardiac Monitoring & Cardiac Rhythm Management Market, By End User, 2016-2025 ($Million)
Table 72.Europe Cardiac Monitoring & Cardiac Rhythm Management Market, By Country, 2016-2025 ($Million)
Table 73.Europe Cardiac Monitoring & Cardiac Rhythm Management Market, By Product, 2016-2025 ($Million)
Table 74.Europe Cardiac Monitoring & Cardiac Rhythm Management Market, By End User, 2016-2025 ($Million)
Table 75.Germany Cardiac Monitoring & Cardiac Rhythm Management Market, By Product, 2016-2025 ($Million)
Table 76.Germany Cardiac Monitoring & Cardiac Rhythm Management Market, By End User, 2016-2025 ($Million)
Table 77.France Cardiac Monitoring & Cardiac Rhythm Management Market, By Product, 2016-2025 ($Million)
Table 78.France Cardiac Monitoring & Cardiac Rhythm Management Market, By End User, 2016-2025 ($Million)
Table 79.UK Cardiac Monitoring & Cardiac Rhythm Management Market, By Product, 2016-2025 ($Million)
Table 80.UK Cardiac Monitoring & Cardiac Rhythm Management Market, By End User, 2016-2025 ($Million)
Table 81.Italy Cardiac Monitoring & Cardiac Rhythm Management Market, By Product, 2016-2025 ($Million)
Table 82.Italy Cardiac Monitoring & Cardiac Rhythm Management Market, By End User, 2016-2025 ($Million)
Table 83.Spain Cardiac Monitoring & Cardiac Rhythm Management Market, By Product, 2016-2025 ($Million)
Table 84.Spain Cardiac Monitoring & Cardiac Rhythm Management Market, By End User, 2016-2025 ($Million)
Table 85.Russia Cardiac Monitoring & Cardiac Rhythm Management Market, By Product, 2016-2025 ($Million)
Table 86.Russia Cardiac Monitoring & Cardiac Rhythm Management Market, By End User, 2016-2025 ($Million)
Table 87.Rest of Europe Cardiac Monitoring & Cardiac Rhythm Management Market, By Product, 2016-2025 ($Million)
Table 88.Rest of Europe Cardiac Monitoring & Cardiac Rhythm Management Market, By End User, 2016-2025 ($Million)
Table 89.Asia-Pacific Cardiac Monitoring & Cardiac Rhythm Management Market, By Country, 2016-2025 ($Million)
Table 90.Asia-Pacific Cardiac Monitoring & Cardiac Rhythm Management Market, By Product, 2016-2025 ($Million)
Table 91.Asia-Pacific Cardiac Monitoring & Cardiac Rhythm Management Market, By End User, 2016-2025 ($Million)
Table 92.Japan Cardiac Monitoring & Cardiac Rhythm Management Market, By Product, 2016-2025 ($Million)
Table 93.Japan Cardiac Monitoring & Cardiac Rhythm Management Market, By End User, 2016-2025 ($Million)
Table 94.China Cardiac Monitoring & Cardiac Rhythm Management Market, By Product, 2016-2025 ($Million)
Table 95.China Cardiac Monitoring & Cardiac Rhythm Management Market, By End User, 2016-2025 ($Million)
Table 96.Australia Cardiac Monitoring & Cardiac Rhythm Management Market, By Product, 2016-2025 ($Million)
Table 97.Australia Cardiac Monitoring & Cardiac Rhythm Management Market, By End User, 2016-2025 ($Million)
Table 98.India Cardiac Monitoring & Cardiac Rhythm Management Market, By Product, 2016-2025 ($Million)
Table 99.India Cardiac Monitoring & Cardiac Rhythm Management Market, By End User, 2016-2025 ($Million)
Table 100.South Korea Cardiac Monitoring & Cardiac Rhythm Management Market, By Product, 2016-2025 ($Million)
Table 101.South Korea Cardiac Monitoring & Cardiac Rhythm Management Market, By End User, 2016-2025 ($Million)
Table 102.Taiwan Cardiac Monitoring & Cardiac Rhythm Management Market, By Product, 2016-2025 ($Million)
Table 103.Taiwan Cardiac Monitoring & Cardiac Rhythm Management Market, By End User, 2016-2025 ($Million)
Table 104.Rest of Asia-Pacific Cardiac Monitoring & Cardiac Rhythm Management Market, By Product, 2016-2025 ($Million)
Table 105.Rest of Asia-Pacific Cardiac Monitoring & Cardiac Rhythm Management Market, By End User, 2016-2025 ($Million)
Table 106.Rest of the World Cardiac Monitoring & Cardiac Rhythm Management Market, By Country, 2016-2025 ($Million)
Table 107.Rest of the World Cardiac Monitoring & Cardiac Rhythm Management Market, By Product, 2016-2025 ($Million)
Table 108.Rest of the World Cardiac Monitoring & Cardiac Rhythm Management Market, By End User, 2016-2025 ($Million)
Table 109.Brazil Cardiac Monitoring & Cardiac Rhythm Management Market, By Product, 2016-2025 ($Million)
Table 110.Brazil Cardiac Monitoring & Cardiac Rhythm Management Market, By End User, 2016-2025 ($Million)
Table 111.Turkey Cardiac Monitoring & Cardiac Rhythm Management Market, By Product, 2016-2025 ($Million)
Table 112.Turkey Cardiac Monitoring & Cardiac Rhythm Management Market, By End User, 2016-2025 ($Million)
Table 113.Saudi Arabia Cardiac Monitoring & Cardiac Rhythm Management Market, By Product, 2016-2025 ($Million)
Table 114.Saudi Arabia Cardiac Monitoring & Cardiac Rhythm Management Market, By End User, 2016-2025 ($Million)
Table 115.South Africa Cardiac Monitoring & Cardiac Rhythm Management Market, By Product, 2016-2025 ($Million)
Table 116.South Africa Cardiac Monitoring & Cardiac Rhythm Management Market, By End User, 2016-2025 ($Million)
Table 117.United Arab Emirates Cardiac Monitoring & Cardiac Rhythm Management Market, By Product, 2016-2025 ($Million)
Table 118.United Arab Emirates Cardiac Monitoring & Cardiac Rhythm Management Market, By End User, 2016-2025 ($Million)
Table 119.Other Cardiac Monitoring & Cardiac Rhythm Management Market, By Product, 2016-2025 ($Million)
Table 120.Other Cardiac Monitoring & Cardiac Rhythm Management Market, By End User, 2016-2025 ($Million)
Table 121.Abiomed: Key Strategic Developments, 2015-2017
Table 122.Berlin Heart GmbH: Key Strategic Developments, 2015-2017
Table 123.BIOTRONIK SE & Co. KG: Key Strategic Developments, 2015-2017
Table 124.Boston Scientific Corporation: Key Strategic Developments, 2015-2017
Table 125.Koninklijke Philips N.V.: Key Strategic Developments, 2015-2017
Table 126.Cardiac Science Corporation: Key Strategic Developments, 2015-2017
Table 127.General Electric Company: Key Strategic Developments, 2015-2017
Table 128.LivaNova PLC: Key Strategic Developments, 2015-2017
Table 129.Medtronic plc: Key Strategic Developments, 2015-2017
Table 130.Nihon Kohden Corporation: Key Strategic Developments, 2015-2017
Table 131.Schiller AG: Key Strategic Developments, 2015-2017
Table 132.ReliantHeart Inc.: Key Strategic Developments, 2015-2017
Table 133.Abbott Laboratories: Key Strategic Developments, 2015-2017


List of Figures

Figure 1.Global Cardiac Monitoring & Cardiac Rhythm Management Market Share, By Product, 2016 & 2025
Figure 2.Cardiac Monitoring & Cardiac Rhythm Management Market, By End User, 2016, ($Million)
Figure 3.Cardiac Monitoring & Cardiac Rhythm Management Market, By Region, 2016, ($Million)
Figure 4.Abiomed: Net Revenues, 2014-2016 ($Million)
Figure 5.Abiomed: Net Revenue Share, By Segment, 2016
Figure 6.Abiomed: Net Revenue Share, By Geography, 2016
Figure 7.Boston Scientific Corporation: Net Revenues, 2014-2016 ($Million)
Figure 8.Boston Scientific Corporation: Net Revenue Share, By Segment, 2016
Figure 9.Boston Scientific Corporation: Net Revenue Share, By Geography, 2016
Figure 10.Koninklijke Philips N.V.: Net Revenues, 2014-2016 ($Million)
Figure 11.Koninklijke Philips N.V.: Net Revenue Share, By Segment, 2016
Figure 12.Koninklijke Philips N.V.: Net Revenue Share, By Geography, 2016
Figure 13.LivaNova PLC: Net Revenues, 2014-2016 ($Million)
Figure 14.LivaNova PLC: Net Revenue Share, By Segment, 2016
Figure 15.LivaNova PLC: Net Revenue Share, By Geography, 2016
Figure 16.Medtronic plc: Net Revenues, 2014-2016 ($Million)
Figure 17.Medtronic plc: Net Revenue Share, By Segment, 2016
Figure 18.Medtronic plc: Net Revenue Share, By Geography, 2016
Figure 19.Nihon Kohden Corporation: Net Revenues, 2014-2016 ($Million)
Figure 20.Nihon Kohden Corporation: Net Revenue Share, By Segment, 2016
Figure 21.Nihon Kohden Corporation: Net Revenue Share, By Geography, 2016
Figure 22.Abbott Laboratories: Net Revenues, 2014-2016 ($Million)
Figure 23.Abbott Laboratories: Net Revenue Share, By Segment, 2016
Figure 24.Abbott Laboratories: Net Revenue Share, By Geography, 2016

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country